Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis

CALR, JAK2, and MPL Mutation Profiles in Patients With Four Different Subtypes of Myeloproliferative Neoplasms

(2015) Seon Young Kim et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutations

(2015) C. Al Assaf et al.   HAEMATOLOGICA

Calreticulin mutation profile in Indian patients with primary myelofibrosis

(2015) Sudha Sazawal et al.   Hematology

JAK2V617F,MPL, andCALRMutations in Korean Patients with Essential Thrombocythemia and Primary Myelofibrosis

(2015) Bo Hyun Kim et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis

(2015) P Guglielmelli et al.   Blood Cancer Journal

Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutations

(2015) C. Al Assaf et al.   HAEMATOLOGICA

CALRmutations in myeloproliferative neoplasms: Hidden behind the reticulum

(2014) Paola Guglielmelli et al.   AMERICAN JOURNAL OF HEMATOLOGY

Primary myelofibrosis: 2014 update on diagnosis, risk-stratification, and management

(2014) Ayalew Tefferi   AMERICAN JOURNAL OF HEMATOLOGY

Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: A collaborative study of 1027 patients

(2014) Ayalew Tefferi et al.   AMERICAN JOURNAL OF HEMATOLOGY

Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis

(2014) E. Rumi et al.   BLOOD

The prognostic advantage of calreticulin mutations in myelofibrosis might be confined to type 1 or type 1-like CALR variants

(2014) A. Tefferi et al.   BLOOD

Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis

(2014) A. Tefferi et al.   BLOOD

Clinical importance of different calreticulin gene mutation types in wild-type JAK2 essential thrombocythemia and myelofibrosis patients

(2014) C. Qiao et al.   HAEMATOLOGICA

JAK2, CALR, and MPL mutation spectrum in Japanese patients with myeloproliferative neoplasms

(2014) S. Shirane et al.   HAEMATOLOGICA

Calreticulin mutations in Chinese with primary myelofibrosis

(2014) B. Li et al.   HAEMATOLOGICA

Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations

(2014) H. Andrikovics et al.   HAEMATOLOGICA

A meta-analysis comparing clinical characteristics and outcomes in CALR-mutated and JAK2V617F essential thrombocythaemia

(2014) Yining Yang et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons

(2014) A Tefferi et al.   LEUKEMIA

Analysis of calreticulin mutations in Chinese patients with essential thrombocythemia: clinical implications in diagnosis, prognosis and treatment

(2014) R Fu et al.   LEUKEMIA

The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients

(2014) P Guglielmelli et al.   LEUKEMIA

Type 1 vs type 2 calreticulin mutations in primary myelofibrosis: differences in phenotype and prognostic impact

(2014) A Tefferi et al.   LEUKEMIA

CALRandASXL1mutation analysis in 190 patients with essential thrombocythemia

(2014) Hongjie Shen et al.   LEUKEMIA & LYMPHOMA

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes

(2013) E. Rumi et al.   BLOOD

Mutations and prognosis in primary myelofibrosis

(2013) A M Vannucchi et al.   LEUKEMIA

Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2

(2013) J. Nangalia et al.   NEW ENGLAND JOURNAL OF MEDICINE

Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms

(2013) Thorsten Klampfl et al.   NEW ENGLAND JOURNAL OF MEDICINE

Guideline for the diagnosis and management of myelofibrosis

(2012) John T. Reilly et al.   BRITISH JOURNAL OF HAEMATOLOGY

A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)

(2009) F. Passamonti et al.   BLOOD

New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment

(2008) F. Cervantes et al.   BLOOD